File(s) not publicly available
Effectiveness of rivastigmine in Alzheimer's disease. Patients' view on quality of life should be assessed.
Version 2 2024-06-03, 18:17Version 2 2024-06-03, 18:17
Version 1 2023-01-31, 05:23Version 1 2023-01-31, 05:23
journal contribution
posted on 2024-06-03, 18:17 authored by CE Selai, MR Trimble, MN Rossor, Richard HarveyRichard HarveyEffectiveness of rivastigmine in Alzheimer's disease. Patients' view on quality of life should be assessed.
History
Journal
BMJ (Clinical research ed.)Volume
319Pagination
641-642Location
EnglandISSN
0959-8138eISSN
1756-1833Language
EnglishPublication classification
CN.1 Other journal articleIssue
7210Publisher
B M J PUBLISHING GROUPUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC